| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |